-
Options Brief: Align Technology (ALGN)
Tuesday, November 30, 2010 - 3:04pm | 92Shares of Align Technology (NASDAQ: ALGN) are lower on the session by 0.51%, currently trading at $17.51. Put volume is currently running at 8.52x the average daily volume, with 77% of all puts traded being purchases on the offer. 1,593 put contracts have traded on the session, so far. Align...
-
Two Stocks Crossing Over Their 50 Day Moving Averages (ANIK, EKB)
Tuesday, November 30, 2010 - 2:35pm | 43Anika Therapeutics, Inc. (NASDAQ: ANIK) and Citigroup Inc. ELKS Based on Dow Chemical Company (NYSE: EKB) have both crossed over their 50 day moving averages, which could be seen as a buying signal in these names.
-
Good News for Merit Medical - Analyst Blog
Tuesday, November 30, 2010 - 12:12pm | 433Recently, Merit Medical Systems (MMSI) received approval from the US Food and Drug Administration (FDA) for the phase III clinical trial protocol to treat primary liver cancer with QuadraSphere microsphere for delivery of doxorubicin. The approval is significant since the late-stage study in...
-
SAC Capital Holdings (ACL, DNDN, GENZ)
Tuesday, November 23, 2010 - 3:41pm | 82SAC Capital run by Stevie Cohen is pretty much almost in every stock, but here is a list put together by Bloomberg, as of September 30. Some of the major holdings in SAC are Dendreon (NASDAQ: DNDN), Genzyme (NASDAQ: GENZ), and Alcon Inc. (NYSE: ACL).
-
Shamir Optical Industry Ltd. Reports Third Quarter EPS of $.25
Tuesday, November 23, 2010 - 9:42am | 112Shamir Optical Industry Ltd. (Nasdaq: SHMR) today announced unaudited financial results for the third quarter ended September 30, 2010. For the quarter ended September 30, 2010, revenues increased 4.7% to $37.8 million, compared with revenues of $36.2 million for the same period in 2009. Gross...
-
Sure Or OSUR? (OSUR)
Monday, November 22, 2010 - 12:43pm | 63OraSure Technologies, Inc. (NASDAQ: OSUR) is up sharply this morning after the company said that regulators approved final testing of its HIV detection test, OraQuick. At last check, shares of OSUR were up 43 cents to $4.92, a gain of 9.5%. Volume is particularly heavy today, as it's traded more...
-
Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, BLUD, VIVO, QDEL)
Wednesday, November 17, 2010 - 4:58am | 128Below are the top diagnostic substance stocks on the NYSE and NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech Plc (NASDAQ: TRIB) is 59.32%. TRIB's ROE for the same period is 56.37%. The trailing-twelve-month profit margin at Immucor Inc (NASDAQ: BLUD) is...
-
Uroplasty Seeing Huge Relative Call Volume (UPI)
Tuesday, November 16, 2010 - 4:04pm | 135Shares of Uroplasty, Inc. (NYSE: UPI) are lower on the session by 6.90%, currently trading at $5.40. The stock has been moving largely higher over the past four months and is currently trading below the 200-day and 50-day moving averages. Options traders are buying calls on the name today. A short...
-
Financials Show Strength 11-15-2010
Monday, November 15, 2010 - 7:25pm | 891Cusick's Corner Strength showed up in the Financials, XLF, and their leadership has pulled the market into the green. I mentioned in the Corner last week to keep an eye on the short-term moving averages as a possible signal for a potentially deeper pullback -- the S&P and NASDAQ have held...
-
Bearish MACD for Medical Action Industries - Tale of the Tape
Friday, November 12, 2010 - 11:33am | 118Medical Action Industries's (MDCI) MACD indicator has moved into bearish territory with a reading of -0.0244. The Zacks #4 Rank (“Sell”) stock decreased more than 1% to $8.90 in the morning trade. The Zacks Consensus Estimate on the company's earnings for the year ending March 2011 has decreased by...
-
Zacks Industry Outlook Highlights: Bayer, Sanofi-Aventis, Alcon, Gilead Sciences and Biogen Idec - Press Releases
Wednesday, November 10, 2010 - 11:33am | 1152For Immediate Release Chicago, IL – November 10, 2010 – Today, Zacks Equity Research discusses the Steel Industry, including Bayer (BAYRY), Sanofi-Aventis (SNY), Alcon (ACL), Gilead Sciences (GILD) and Biogen Idec (BIIB). A synopsis of today's Industry Outlook is presented below. The full article...
-
Span-America Declares Quarterly Dividend of $.10
Wednesday, November 10, 2010 - 10:45am | 40Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors declared a regular quarterly dividend of $0.10 per share. The dividend is payable December 3, 2010, to shareholders of record on November 24, 2010.
-
TranS1 Posts In-Line Quarter; Management Trims Full Year Guidance
Wednesday, November 10, 2010 - 8:54am | 210TranS1's (NASDAQ: TSON) results were a touch ahead of Piper Jaffray's estimates and in-line with guidance, but management trimmed full-year guidance based on a late quarter increase in payor pressure and case cancellations, similar to the late-September and October trends described recently by...
-
Piper Jaffray Initiates Coverage On Merit Medical Systems
Wednesday, November 10, 2010 - 8:39am | 216Piper Jaffray is initiating coverage of Merit Medical Systems (NASDAQ: MMSI) with an Overweight rating and a 12-month price target of $20 based on MMSI trading at ~20x our C11 EPS estimate of $0.98. Merit Medical manufactures a broad array of complementary medical devices used in interventional...
-
Pharma & Biotech Industry Outlook - Nov. 2010 - Zacks Analyst Interviews
Tuesday, November 9, 2010 - 6:03pm | 2720With 2010 coming to an end, the pharmaceutical industry continues to witness major challenges like sluggish prescription trends, EU pricing pressure, intensifying generic competition and limited late-stage catalysts. The next five years are expected to reflect a significant imbalance between new...